GlassScriptPhysician profile
Maycen E Wiseman
NPI 1811581614
$402.74
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.62 · 2023: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.84 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $59.74 | 2023 | |
| Acorda Therapeutics, INC | $51.18 | 2023 | Inbrija, Ampyra |
| Ucb, INC. | $38.63 | 2023 | Briviact |
| Mallinckrodt Hospital Products INC. | $35.15 | 2023 | Acthar |
| Sk Life Science, INC. | $34.32 | 2023 | |
| Catalyst Pharmaceuticals, INC. | $29.06 | 2023 | Firdapse |
| Alexion Pharmaceuticals, INC. | $28.29 | 2022-2023 | Soliris |
| Emd Serono, INC. | $18.65 | 2023 | Mavenclad |
| Lilly USA, LLC | $17.71 | 2023 | Reyvow, Emgality |
| Impel Pharmaceuticals INC. | $15.17 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maycen Wiseman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.